Treatment of Uncomplicated UTI in Adults
For uncomplicated cystitis in women, start with nitrofurantoin 100 mg twice daily for 5 days, fosfomycin 3 g single dose, or pivmecillinam 400 mg three times daily for 3-5 days as first-line therapy. 1
First-Line Treatment Options for Women with Uncomplicated Cystitis
The 2024 European Association of Urology guidelines provide clear first-line recommendations 1:
- Fosfomycin trometamol: 3 g single dose (recommended only for women with uncomplicated cystitis)
- Nitrofurantoin: 100 mg twice daily for 5 days (multiple formulations available)
- Pivmecillinam: 400 mg three times daily for 3-5 days
These agents are prioritized because they achieve high urinary concentrations, maintain good efficacy against common uropathogens (primarily E. coli), and minimize collateral damage to normal flora 2, 3.
Alternative Agents (Second-Line)
Use these when first-line options are contraindicated or unavailable 1:
- Trimethoprim: 200 mg twice daily for 5 days (avoid in first trimester of pregnancy)
- Trimethoprim-sulfamethoxazole: 160/800 mg twice daily for 3 days (avoid in last trimester of pregnancy)
- Cephalosporins (e.g., cefadroxil 500 mg twice daily for 3 days): Only if local E. coli resistance is <20%
Critical caveat: Fluoroquinolones should NOT be used for uncomplicated cystitis due to safety concerns and the need to preserve them for more serious infections 1, 4. β-lactams like amoxicillin-clavulanate are less effective as empirical first-line therapy 5.
Treatment for Men with Uncomplicated UTI
Men require longer treatment duration 1, 3:
- Trimethoprim-sulfamethoxazole: 160/800 mg twice daily for 7 days
- Trimethoprim: 7 days
- Nitrofurantoin: 7 days
Important consideration: Always obtain urine culture in men before treatment, as UTIs in men warrant investigation for underlying urologic abnormalities and consideration of prostatitis 3.
Diagnosis: When Testing is Actually Needed
For women with typical symptoms (dysuria, frequency, urgency, suprapubic pain) and no vaginal discharge, clinical diagnosis alone is sufficient—no urine culture needed 1, 3. This is a key point that reduces unnecessary testing.
Obtain urine culture only when 1:
- Suspected pyelonephritis
- Symptoms persist or recur within 4 weeks after treatment
- Atypical presentation
- Pregnancy
- Men with UTI symptoms
- History of resistant organisms
Alternative to Antibiotics: Symptomatic Treatment
For women with mild to moderate symptoms, symptomatic therapy with NSAIDs (e.g., ibuprofen) may be considered as an alternative to immediate antibiotics after discussing risks and benefits with the patient 1, 3. This approach acknowledges that uncomplicated cystitis has a low risk of progression to serious complications. However, this requires careful patient selection and close follow-up.
Treatment Duration Matters
The 2024 guidelines emphasize specific durations based on robust evidence 2:
- Nitrofurantoin: 5 days (clear recommendation)
- Fosfomycin: Single dose (clear recommendation)
- Fluoroquinolones (if used): 3 days for cystitis
- Pivmecillinam: 3 days (clear recommendation)
- TMP/SMX: 3 days (clear recommendation)
Shorter courses reduce adverse effects and antimicrobial resistance without compromising efficacy.
When Treatment Fails
If symptoms don't resolve by end of treatment or recur within 2 weeks 1:
- Obtain urine culture with susceptibility testing
- Assume the organism is resistant to the initial agent
- Retreat with a 7-day course of a different antimicrobial
Do not perform routine post-treatment cultures in asymptomatic patients—this is unnecessary and can lead to overtreatment of asymptomatic bacteriuria 1.
Special Populations
Older adults (≥65 years): Use the same first-line agents and durations as younger adults, but obtain urine culture to guide therapy adjustment if needed 3.
Pregnant women: Screen for and treat asymptomatic bacteriuria; use nitrofurantoin (avoid near term), fosfomycin, or cephalosporins; avoid trimethoprim in first trimester and sulfonamides near delivery 1.
Resistance Considerations
Local resistance patterns should guide empirical choices 4, 6. In areas where E. coli resistance to TMP/SMX exceeds 20%, or in patients with recent antibiotic exposure, avoid these agents and use nitrofurantoin or fosfomycin instead. This is why nitrofurantoin and fosfomycin are increasingly favored—they maintain low resistance rates globally.